Compositions comprising cells expressing cold- and menthol-sensitive receptor (CMR1) polypeptides
US-9063125-B2 · Jun 23, 2015 · US
US9932383B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9932383-B2 |
| Application number | US-201615266016-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 15, 2016 |
| Priority date | Jan 25, 2002 |
| Publication date | Apr 3, 2018 |
| Grant date | Apr 3, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to regulation of cold sensation and pain. More particularly, the present invention is directed to nucleic acids encoding a member of the transient regulatory protein family, CMR1, which is involved in modulation of the perception of cold sensations and pain. In some embodiments, an isolated or recombinant CMR1 polypeptide is directly or indirectly attached to a detectable label or fused to a second polypeptide. In some embodiments, an isolated or recombinant CMR1 polypeptide is directly or indirectly bound to a solid support.
Opening claim text (preview).
What is claimed is: 1. An isolated or recombinant cold- and menthol-sensitive receptor (CMR1) polypeptide comprising SEQ ID NO:3 directly or indirectly attached to a detectable label or fused to a second polypeptide. 2. The isolated or recombinant polypeptide of claim 1 , wherein the CMR1 polypeptide is fused to a second polypeptide. 3. The isolated or recombinant polypeptide of claim 1 , wherein the label is selected from 32 P, fluorescent dyes, electron-dense reagents, biotin, digoxygenin, haptens, and radiolabeled proteins. 4. An isolated membrane comprising the isolated or recombinant polypeptide of claim 1 . 5. An isolated membrane comprising the isolated or recombinant polypeptide of claim 2 . 6. An isolated membrane comprising the isolated or recombinant polypeptide of claim 3 . 7. An isolated or recombinant cold- and menthol-sensitive receptor (CMR1) polypeptide comprising SEQ ID NO:3 directly or indirectly bound to a solid support. 8. The isolated or recombinant polypeptide of claim 7 , wherein the CMR1 polypeptide is bound covalently to the solid support. 9. The isolated or recombinant polypeptide of claim 7 , wherein the CMR1 polypeptide is bound non-covalently to the solid support. 10. The isolated or recombinant polypeptide of claim 7 , wherein the solid support comprises a nitrocellulose filter, a nylon filter, or a derivatized nylon filter.
involving analysis of members of signalling pathways · CPC title
Fusion polypeptide · CPC title
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00) · CPC title
Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)} · CPC title
Assays involving receptors, cell surface antigens or cell surface determinants · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.